Pharmicell Co (XKRX:005690) Short-Term Capital Lease Obligation : ₩326 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Pharmicell Co Short-Term Capital Lease Obligation?

Pharmicell Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩326 Mil.

Pharmicell Co's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (₩147 Mil) to Dec. 2023 (₩196 Mil) and increased from Dec. 2023 (₩196 Mil) to Mar. 2024 (₩326 Mil).

Pharmicell Co's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (₩115 Mil) to Dec. 2022 (₩114 Mil) but then increased from Dec. 2022 (₩114 Mil) to Dec. 2023 (₩196 Mil).

Pharmicell Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Pharmicell Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmicell Co Short-Term Capital Lease Obligation Chart

Pharmicell Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

29.67

30.65

115.13

114.18

195.54

Pharmicell Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															213.68	149.21	146.86	195.54	325.70

Pharmicell Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Pharmicell Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Pharmicell Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmicell Co (XKRX:005690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmicell Co Ltd (XKRX:005690) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F Chungho B/D, 3-2 Nonhyun-dong Gangnam-gu, Seoul, KOR, 135-010

Website

http://www.pharmicell.com

Pharmicell Co Ltd is a biotechnology company, engages in the manufacturing of biopharmaceutical medicines in South Korea. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. Its products under development include mesenchymal stem cell products, such as Cellgram_AMI, a heart disease drug; Cellgram_IS and Cellgram_SCI, which are brain/nerve disorder drugs; Cellgram_Lung, a pulmonary disease drug; Cellgram_LC, a liver disease drug; and Cellgram_ED and Cellgram_CLI for the treatment of graft-versus-host disease, kidney transplant, impotence, and critical lower limb ischemia.

Pharmicell Co (XKRX:005690) Headlines

No Headlines